chrX-154030632-G-A

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2

The NM_001110792.2(MECP2):​c.1232C>T​(p.Pro411Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000516 in 1,201,770 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 19 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000074 ( 0 hom., 0 hem., cov: 20)
Exomes 𝑓: 0.000049 ( 0 hom. 19 hem. )

Consequence

MECP2
NM_001110792.2 missense

Scores

1
7
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.69
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07669163).
BP6
Variant X-154030632-G-A is Benign according to our data. Variant chrX-154030632-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 143430.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154030632-G-A is described in Lovd as [Benign].
BS2
High Hemizygotes in GnomAdExome4 at 19 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MECP2NM_001110792.2 linkuse as main transcriptc.1232C>T p.Pro411Leu missense_variant 3/3 ENST00000453960.7 NP_001104262.1
MECP2NM_004992.4 linkuse as main transcriptc.1196C>T p.Pro399Leu missense_variant 4/4 ENST00000303391.11 NP_004983.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MECP2ENST00000453960.7 linkuse as main transcriptc.1232C>T p.Pro411Leu missense_variant 3/31 NM_001110792.2 ENSP00000395535 P51608-2
MECP2ENST00000303391.11 linkuse as main transcriptc.1196C>T p.Pro399Leu missense_variant 4/41 NM_004992.4 ENSP00000301948 P1P51608-1
MECP2ENST00000407218.5 linkuse as main transcriptc.*568C>T 3_prime_UTR_variant 4/45 ENSP00000384865
MECP2ENST00000628176.2 linkuse as main transcriptc.*568C>T 3_prime_UTR_variant 5/53 ENSP00000486978

Frequencies

GnomAD3 genomes
AF:
0.0000740
AC:
8
AN:
108172
Hom.:
0
Cov.:
20
AF XY:
0.00
AC XY:
0
AN XY:
30504
show subpopulations
Gnomad AFR
AF:
0.0000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000967
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000511
AC:
9
AN:
176102
Hom.:
0
AF XY:
0.0000466
AC XY:
3
AN XY:
64426
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000210
Gnomad FIN exome
AF:
0.000152
Gnomad NFE exome
AF:
0.0000254
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000494
AC:
54
AN:
1093551
Hom.:
0
Cov.:
34
AF XY:
0.0000526
AC XY:
19
AN XY:
360893
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000569
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000331
Gnomad4 SAS exome
AF:
0.0000370
Gnomad4 FIN exome
AF:
0.0000544
Gnomad4 NFE exome
AF:
0.0000547
Gnomad4 OTH exome
AF:
0.0000217
GnomAD4 genome
AF:
0.0000739
AC:
8
AN:
108219
Hom.:
0
Cov.:
20
AF XY:
0.00
AC XY:
0
AN XY:
30561
show subpopulations
Gnomad4 AFR
AF:
0.0000337
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000832
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000967
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000378
ExAC
AF:
0.0000660
AC:
8
EpiCase
AF:
0.000164
EpiControl
AF:
0.000119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenSep 01, 2023MECP2: BS2 -
Likely benign, criteria provided, single submitterclinical testingGeneDxDec 02, 2020This variant is associated with the following publications: (PMID: 11309367, 12161600, 23810759) -
not specified Benign:1
Benign, no assertion criteria providedcurationRettBASEDec 05, 2013- -
Severe neonatal-onset encephalopathy with microcephaly Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Rett syndrome Benign:1
Benign, criteria provided, single submittercurationCentre for Population Genomics, CPGAug 14, 2023This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria.Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders to the ACMG/AMP Variant Interpretation Guidelines VCEP 2.0 , this variant is classified as Benign . At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is higher than the 0.03% threshold defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 2.0 (BA1). -
MECP2-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJan 27, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.26
T;.
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.94
D;D
M_CAP
Pathogenic
0.50
D
MetaRNN
Benign
0.077
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N;.
MutationTaster
Benign
0.98
D;D
PrimateAI
Uncertain
0.57
T
PROVEAN
Benign
-0.40
N;N
REVEL
Uncertain
0.36
Sift
Uncertain
0.0030
D;D
Sift4G
Uncertain
0.027
D;D
Polyphen
0.089
B;B
Vest4
0.15
MVP
0.95
ClinPred
0.047
T
GERP RS
3.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.13
gMVP
0.21

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs62915962; hg19: chrX-153296083; API